The global benzodiazepine APIs market is experiencing steady growth due to the increasing prevalence of anxiety disorders, insomnia, seizures, and other neurological conditions worldwide. The market was valued at US$ 472.8 Mn in 2022 and is projected to surpass US$ 652.8 Mn by 2031, expanding at a CAGR of 3.6% from 2023 to 2031. Growing awareness of mental health issues, rising healthcare...